Free Trial

Johnson & Johnson (JNJ) Competitors

Johnson & Johnson logo
$188.50 +2.53 (+1.36%)
Closing price 10/3/2025 03:59 PM Eastern
Extended Trading
$188.74 +0.24 (+0.12%)
As of 10/3/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

JNJ vs. ISRG, MRNA, NVAX, ABBV, BRK.B, LLY, MRK, PFE, PG, and XOM

Should you be buying Johnson & Johnson stock or one of its competitors? The main competitors of Johnson & Johnson include Intuitive Surgical (ISRG), Moderna (MRNA), Novavax (NVAX), AbbVie (ABBV), Berkshire Hathaway (BRK.B), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), Pfizer (PFE), Procter & Gamble (PG), and Exxon Mobil (XOM).

Johnson & Johnson vs. Its Competitors

Johnson & Johnson (NYSE:JNJ) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

In the previous week, Johnson & Johnson had 49 more articles in the media than Intuitive Surgical. MarketBeat recorded 112 mentions for Johnson & Johnson and 63 mentions for Intuitive Surgical. Johnson & Johnson's average media sentiment score of 1.34 beat Intuitive Surgical's score of 1.02 indicating that Johnson & Johnson is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Johnson & Johnson
88 Very Positive mention(s)
5 Positive mention(s)
12 Neutral mention(s)
3 Negative mention(s)
2 Very Negative mention(s)
Positive
Intuitive Surgical
41 Very Positive mention(s)
4 Positive mention(s)
11 Neutral mention(s)
4 Negative mention(s)
1 Very Negative mention(s)
Positive

Johnson & Johnson currently has a consensus target price of $188.88, indicating a potential upside of 0.20%. Intuitive Surgical has a consensus target price of $594.19, indicating a potential upside of 31.36%. Given Intuitive Surgical's higher possible upside, analysts clearly believe Intuitive Surgical is more favorable than Johnson & Johnson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Johnson & Johnson
0 Sell rating(s)
9 Hold rating(s)
11 Buy rating(s)
2 Strong Buy rating(s)
2.68
Intuitive Surgical
1 Sell rating(s)
7 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.59

Johnson & Johnson has higher revenue and earnings than Intuitive Surgical. Johnson & Johnson is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Johnson & Johnson$88.82B5.11$14.07B$9.3520.16
Intuitive Surgical$8.35B19.42$2.32B$7.1763.09

Intuitive Surgical has a net margin of 28.51% compared to Johnson & Johnson's net margin of 25.00%. Johnson & Johnson's return on equity of 32.49% beat Intuitive Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Johnson & Johnson25.00% 32.49% 13.00%
Intuitive Surgical 28.51%14.56%12.93%

Johnson & Johnson has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500.

69.6% of Johnson & Johnson shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 0.2% of Johnson & Johnson shares are owned by insiders. Comparatively, 0.7% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Johnson & Johnson beats Intuitive Surgical on 9 of the 17 factors compared between the two stocks.

Get Johnson & Johnson News Delivered to You Automatically

Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JNJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JNJ vs. The Competition

MetricJohnson & JohnsonLarge Cap Pharma IndustryMedical SectorNYSE Exchange
Market Cap$454.31B$275.83B$6.13B$21.82B
Dividend Yield2.76%2.49%5.66%3.54%
P/E Ratio20.1631.9286.8829.81
Price / Sales5.115.33605.4267.73
Price / Cash14.3814.8126.3018.31
Price / Book6.3520.1912.534.65
Net Income$14.07B$8.49B$3.30B$1.00B
7 Day Performance4.91%8.65%4.28%2.07%
1 Month Performance5.79%5.45%6.90%3.33%
1 Year Performance17.60%-1.74%70.54%13.11%

Johnson & Johnson Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JNJ
Johnson & Johnson
4.7023 of 5 stars
$188.51
+1.4%
$188.88
+0.2%
+17.6%$454.31B$88.82B20.16138,100Trending News
Analyst Forecast
ISRG
Intuitive Surgical
4.9527 of 5 stars
$441.14
+0.0%
$595.95
+35.1%
-6.1%$158.23B$8.35B61.5615,638Trending News
Analyst Forecast
MRNA
Moderna
4.1551 of 5 stars
$25.46
+4.0%
$41.81
+64.2%
-52.7%$9.91B$3.24B-3.385,800Options Volume
NVAX
Novavax
4.3195 of 5 stars
$8.58
+0.3%
$14.29
+66.6%
-30.5%$1.39B$682.16M3.771,990Options Volume
ABBV
AbbVie
4.6229 of 5 stars
$221.38
+0.3%
$223.45
+0.9%
+20.5%$391.27B$56.33B105.4755,000Trending News
Analyst Downgrade
BRK.B
Berkshire Hathaway
2.2508 of 5 stars
$498.60
-0.3%
$575.00
+15.3%
+8.1%$1.08T$371.43B17.09392,400Trending News
LLY
Eli Lilly and Company
4.9907 of 5 stars
$725.66
+0.2%
$939.61
+29.5%
-5.2%$687.05B$45.04B47.4547,000Trending News
Analyst Forecast
Options Volume
MRK
Merck & Co., Inc.
4.9957 of 5 stars
$78.67
+0.1%
$106.41
+35.3%
-18.7%$196.40B$64.17B12.1275,000News Coverage
Positive News
Options Volume
PFE
Pfizer
4.8733 of 5 stars
$23.85
+0.4%
$28.12
+17.9%
-4.3%$135.56B$63.63B12.6881,000Trending News
Analyst Forecast
PG
Procter & Gamble
4.6621 of 5 stars
$153.13
+0.4%
$173.68
+13.4%
-9.9%$358.22B$84.28B23.51109,000News Coverage
Positive News
Analyst Forecast
XOM
Exxon Mobil
4.891 of 5 stars
$114.06
-2.7%
$125.00
+9.6%
-9.2%$485.96B$349.59B16.1961,000Trending News

Related Companies and Tools


This page (NYSE:JNJ) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners